Chase Knickerbocker
Stock Analyst at Craig-Hallum
(2.11)
# 1,550
Out of 4,667 analysts
29
Total ratings
38.46%
Success rate
-1.54%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $3.36 | +257.14% | 2 | Nov 14, 2024 | |
| KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $3.65 | +36.99% | 1 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $3.49 | +186.53% | 1 | Nov 4, 2024 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $10 → $15 | $10.43 | +43.82% | 3 | Oct 28, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $10.58 | +51.23% | 3 | Oct 11, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $65 | $42.44 | +53.16% | 3 | Oct 4, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $17 → $15 | $4.64 | +223.28% | 4 | Aug 14, 2024 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $14 → $10 | $3.52 | +184.09% | 3 | Aug 9, 2024 | |
| MDXG MiMedx Group | Maintains: Buy | $14 → $12 | $9.06 | +32.45% | 2 | Aug 1, 2024 | |
| CDRO Codere Online Luxembourg | Initiates: Buy | $10 | $7.30 | +36.99% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $9.63 | +86.92% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $10.75 | +113.95% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.41 | +191.26% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $8.73 | +140.55% | 1 | Mar 13, 2023 |
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $3.36
Upside: +257.14%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $4 → $5
Current: $3.65
Upside: +36.99%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $3.49
Upside: +186.53%
Eton Pharmaceuticals
Oct 28, 2024
Maintains: Buy
Price Target: $10 → $15
Current: $10.43
Upside: +43.82%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $10.58
Upside: +51.23%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $42.44
Upside: +53.16%
Fennec Pharmaceuticals
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $4.64
Upside: +223.28%
Ironwood Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $14 → $10
Current: $3.52
Upside: +184.09%
MiMedx Group
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $9.06
Upside: +32.45%
Codere Online Luxembourg
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $7.30
Upside: +36.99%
Jun 28, 2024
Initiates: Buy
Price Target: $18
Current: $9.63
Upside: +86.92%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $10.75
Upside: +113.95%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.41
Upside: +191.26%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $8.73
Upside: +140.55%